Pictet Asset Management (Switzerland)’s Royalty Pharma RPRX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio RPRX Stock Details RPRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$21.7M	Buy
2023 Q1	$20.8M	Buy
2022 Q4	$8.49M	Buy
2022 Q3	$7.68M	Buy
2022 Q2	$4.87M	Sell
2022 Q1	$4.57M	Buy
2021 Q4	$4.61M	Buy
2021 Q3	$2.16M	Buy